239 related articles for article (PubMed ID: 10832450)
1. [Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation].
Tsukagoshi S
Gan To Kagaku Ryoho; 2000 May; 27(5):767-74. PubMed ID: 10832450
[TBL] [Abstract][Full Text] [Related]
2. [Molecular specificity of nafamostat mesilate (FUT), a drug used for the treatments of DIC and acute pancreatitis and as an anticoagulant--the pharmacodynamics and pharmacological action].
Tsukagoshi S
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1237-43. PubMed ID: 11579633
[TBL] [Abstract][Full Text] [Related]
3. [Beneficial characteristics of protease inhibitor as an anticoagulant for extracorporeal circulation].
Akizawa T
Rinsho Ketsueki; 1990 Jun; 31(6):782-6. PubMed ID: 2214168
[TBL] [Abstract][Full Text] [Related]
4. The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).
Mellgren K; Skogby M; Friberg LG; Tengborn L; Wadenvik H
Thromb Haemost; 1998 Feb; 79(2):342-7. PubMed ID: 9493588
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
[TBL] [Abstract][Full Text] [Related]
7. [The effects of FUT-175 (nafamostat mesilate) on blood coagulation and experimental disseminated intravascular coagulation (DIC)].
Koshiyama Y; Kobori A; Ogihara M; Yokomoto Y; Ohtani K; Shimamura K; Iwaki M
Nihon Yakurigaku Zasshi; 1987 Dec; 90(6):313-20. PubMed ID: 3443413
[TBL] [Abstract][Full Text] [Related]
8. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
Dabrowski A; Gabryelewicz A
J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of FUT-175, protease inhibitor, as an anticoagulant to hemodialysis].
Pak K; Shirasu A; Okino K; Sako H; Nakane Y; Umemura K; Maeda S; Tomoyoshi T
Hinyokika Kiyo; 1988 Jun; 34(6):1077-81. PubMed ID: 3223453
[TBL] [Abstract][Full Text] [Related]
12. [Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
Aramoto H; Saito H; Shigematsu H; Muto T
Nihon Rinsho; 1993 Jan; 51(1):93-8. PubMed ID: 8433532
[TBL] [Abstract][Full Text] [Related]
13. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis].
Iwaki M; Ozeki M; Sato T; Suzuki K; Motoyoshi A; Suzuki S; Fujita M; Aoyama T
Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):363-72. PubMed ID: 6210233
[TBL] [Abstract][Full Text] [Related]
15. Gabexate mesilate (Foy) as an anticoagulant in extracorporeal circulation in dogs and sheep.
Oedekoven B; Bey R; Mottaghy K; Schmid-Schönbein H
Thromb Haemost; 1984 Dec; 52(3):329-32. PubMed ID: 6442472
[TBL] [Abstract][Full Text] [Related]
16. Blood platelet function in canine acute pancreatitis with reference to treatment with Nafamostat mesilate (FUT-175).
Lukaszyk A; Bodzenta-Lukaszyk A; Gabryelewicz A; Bielawiec M
Thromb Res; 1992 Jan; 65(2):229-39. PubMed ID: 1579898
[TBL] [Abstract][Full Text] [Related]
17. Application of a new anticoagulant (Nafamostat Mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation--a preliminary report.
Nagaya M; Futamura M; Kato J; Niimi N; Fukuta S
J Pediatr Surg; 1997 Apr; 32(4):531-5. PubMed ID: 9126748
[TBL] [Abstract][Full Text] [Related]
18. Plasma collection using nafamostat mesilate and dipyridamole as an anticoagulant.
Hiraishi M; Yamazaki Z; Ichikawa K; Kanai F; Idezuki Y; Onishi K; Takahama T; Inoue N
Int J Artif Organs; 1988 May; 11(3):212-6. PubMed ID: 3403059
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of platelet aggregation and prevention of endotoxin-induced DIC by a protease inhibitor, FUT-175, in rats].
Yoshikawa T; Murakami M; Furukawa Y; Onodera H; Yoshida N; Ueda M; Kato H; Takemura S; Sugino S; Kondo M
Masui; 1984 Apr; 33(4):397-402. PubMed ID: 6471360
[No Abstract] [Full Text] [Related]
20. [Effects of new protease inhibitor (FUT-175) on experimental DIC].
Denno R; Hasegawa I; Sasaki K; Gotoh Y; Ebata T; Totsuka M; Hayasaka H
Masui; 1984 Feb; 33(2):125-30. PubMed ID: 6716646
[No Abstract] [Full Text] [Related]
[Next] [New Search]